0
Editor's Correspondence |

Inappropriate Fluoroquinolone Use Resulting From Lack of Specific Guidelines

Join Y. Luh, MD; Bernard M. Karnath, MD
Arch Intern Med. 2003;163(16):1978. doi:10.1001/archinte.163.16.1978.
Text Size: A A A
Published online

Extract

The study by Malcom and Marrie1 reveals the alarming prevalence of inappropriate fluoroquinolone use for community-acquired pneumonia (CAP) in a sample of emergency departments. Community-acquired pneumonia remains the most common infectious cause of death; thus, the widespread use of fluoroquinolones leading to emergence of resistant pneumococcus and gram-negative organisms seldom implicated in CAP is worrisome.2 One of the obstacles in educating practitioners treating CAP to limit the use of fluoroquinolones to those deemed appropriate for such therapy1 is the lack specific recommendations for the treatment of CAP by guidelines published by the American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA). In outpatient CAP, the IDSA recommends doxycycline, a macrolide, or a fluoroquinolone in no specific order of preference.3 Although the latest ATS guidelines for outpatient treatment of CAP recommend reserving fluoroquinolones for patients with cardiopulmonary disease, the ATS makes no distinction in preference among a β-lactam plus a macrolide, a β-lactam plus doxycycline, or an intravenous fluoroquinolone alone in stable hospitalized patients with comorbidities. In hospitalized patients without cardiopulmonary risk factors, monotherapy with intravenous azithromycin or a fluoroquinolone are recommended equally, despite significant differences in their spectrums of coverage.4 For hospitalized non–intensive care unit patients, the IDSA recommends an extended spectrum cephalosporin plus a macrolide, or a β-lactam/lactamase inhibitor plus a macrolide, or a fluoroquinolone alone—equally as first-line therapy. In intensive care unit patients, the IDSA recommends an extended spectrum cephalosporin or β-lactam/β-lactamase inhibitor plus a fluoroquinolone or macrolide without preference for either combination of the latter.3 In the United States, only the Centers for Disease Control and Prevention Drug Resistant Streptococcus pneumoniae Therapeutic Working Group (CDC-DRSPWG) and the Antibiotic Selection for Community Acquired Pneumonia (ASCAP) panel consistently recognize the potential impact of widespread fluoroquinolone resistance due to its widespread use, as well as the need to reserve fluoroquinolones for selected patients with CAP, in the outpatient, inpatient, and intensive care unit settings.5,6 In view of such variance in guidelines in the United States, it is not surprising that confusion over what should be considered first-line empiric therapy for CAP has led to a high level of inappropriate fluoroquinolone use in our hospitals, emergency departments, and clinics.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();